Spruce Biosciences (SPRB) Short Interest Ratio & Short Volume $0.12 0.00 (-3.50%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.12 0.00 (-3.12%) As of 04/17/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Spruce Biosciences Short Interest DataSpruce Biosciences (SPRB) has a short interest of 136,400 shares, representing 0.36% of the float (the number of shares available for trading by the public). This marks a -48.68% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 613,940 shares to cover all short positions.Current Short Interest136,400 sharesPrevious Short Interest265,800 sharesChange Vs. Previous Month-48.68%Dollar Volume Sold Short$39,569.64Short Interest Ratio0.4 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares42,231,000 sharesShort Percent of Float0.36%Today's Trading Volume3,977,172 sharesAverage Trading Volume613,940 sharesToday's Volume Vs. Average648% Short Selling Spruce Biosciences? Sign up to receive the latest short interest report for Spruce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSPRB Short Interest Over TimeSPRB Days to Cover Over TimeSPRB Percentage of Float Shorted Over Time Spruce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025136,400 shares $39,569.64 -48.7%0.4%0.4 $0.29 3/15/2025265,800 shares $89,069.58 -37.5%0.7%0.7 $0.34 2/28/2025425,100 shares $165,363.90 -5.0%1.1%0.7 $0.39 2/15/2025447,300 shares $181,380.15 +81.4%1.2%0.8 $0.41 1/31/2025246,600 shares $92,475.00 -44.6%N/A0.4 $0.38 1/15/2025444,900 shares $164,835.45 +315.4%N/A0.8 $0.37 12/31/2024107,100 shares $44,982.00 -51.1%N/A0.2 $0.42 12/15/2024219,000 shares $83,920.80 +613.4%N/A0.4 $0.38 11/30/202430,700 shares $16,792.90 -56.8%N/A0.1 $0.55 11/15/202471,000 shares $34,832.60 -69.5%N/A0.2 $0.49 Get the Latest News and Ratings for SPRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024232,800 shares $123,663.36 -18.4%N/A0.6 $0.53 10/15/2024285,200 shares $133,245.44 -20.8%N/A0.7 $0.47 9/30/2024359,900 shares $170,916.51 +44.5%N/A0.8 $0.47 9/15/2024249,000 shares $115,859.70 -1.2%N/A0.6 $0.47 8/31/2024252,100 shares $117,150.87 +22.7%N/A0.6 $0.46 8/15/2024205,400 shares $90,355.46 +52.2%N/A0.4 $0.44 7/31/2024135,000 shares $69,795.00 -23.6%N/A0.3 $0.52 7/15/2024176,800 shares $102,508.64 -28.7%N/A0.4 $0.58 6/30/2024248,100 shares $128,441.37 +103.9%N/A0.5 $0.52 6/15/2024121,700 shares $79,068.49 +202.0%N/A0.2 $0.65 5/31/202440,300 shares $29,866.33 -67.3%N/A0 $0.74 5/15/2024123,300 shares $98,640.00 -42.8%N/A0.1 $0.80 4/30/2024215,500 shares $152,574.00 +31.4%1.0%0.2 $0.71 4/15/2024164,000 shares $115,734.80 -48.8%0.7%0.1 $0.71 3/31/2024320,400 shares $251,802.36 +69.3%1.5%0.3 $0.79 3/15/2024189,300 shares $152,954.40 +461.7%N/A0.2 $0.81 2/29/202433,700 shares $168,500.00 -33.0%0.2%0.1 $5.00 2/15/202450,300 shares $254,518.00 +17.3%0.3%0.2 $5.06 1/31/202442,900 shares $157,014.00 +117.8%N/A0.2 $3.66 1/15/202419,700 shares $48,856.00 -74.4%N/A0.1 $2.48 12/31/202377,000 shares $225,610.00 +64.5%N/A0.4 $2.93 12/15/202346,800 shares $77,688.00 -10.5%N/A0.3 $1.66 11/30/202352,300 shares $73,220.00 -24.0%N/A0.4 $1.40 11/15/202368,800 shares $79,120.00 +94.4%N/A0.6 $1.15 10/31/202335,400 shares $40,356.00 +49.4%N/A0.4 $1.14 10/15/202323,700 shares $37,683.00 -38.1%N/A0.3 $1.59 9/30/202338,300 shares $86,558.00 -53.4%N/A0.5 $2.26 9/15/202382,100 shares $201,966.00 +203.0%N/A1.1 $2.46 8/31/202327,100 shares $60,975.00 -14.0%N/A0.4 $2.25 8/15/202331,500 shares $68,040.00 -70.4%N/A0.3 $2.16Claim Your FREE Protection Guide (Ad)In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now → 7/31/2023106,500 shares $239,625.00 +31.5%N/A0.8 $2.25 7/15/202381,000 shares $167,670.00 -16.3%N/A0.6 $2.07 6/30/202396,800 shares $208,120.00 +497.5%N/A0.6 $2.15 6/15/202316,200 shares $38,232.00 -96.6%N/A0.1 $2.36 5/31/2023470,900 shares $1.14 million -59.1%N/A2.9 $2.43 5/15/20231,150,000 shares $2.51 million -12.9%N/A6.6 $2.18 4/30/20231,320,000 shares $2.72 million -6.4%N/A7 $2.06 4/15/20231,410,000 shares $2.74 million +16.5%N/A6.5 $1.94 3/31/20231,210,000 shares $2.67 million +15.2%N/A2.6 $2.21 3/15/20231,050,000 shares $2.37 million -3.7%N/A0.7 $2.26 2/28/20231,090,000 shares $2.47 million +30.0%N/A0.7 $2.27 2/15/2023838,400 shares $2.29 million +1.6%13.6%0.6 $2.73 1/31/2023825,400 shares $2.43 million -31.8%6.8%0.6 $2.95 1/15/20231,210,000 shares $3.34 million +77.1%10.0%0.9 $2.76 12/30/2022683,100 shares $749,633.94 +16.1%5.6%0.5 $1.10 12/15/2022588,600 shares $588,600.00 +17.5%4.9%9.7 $1.00 11/30/2022500,900 shares $550,990.00 +52.3%4.1%9.3 $1.10 11/15/2022328,900 shares $345,345.00 +23.2%2.7%6.4 $1.05 10/31/2022267,000 shares $296,370.00 +211.9%2.2%7.9 $1.11 10/15/202285,600 shares $97,584.00 +40.1%0.7%2.6 $1.14 9/30/202261,100 shares $83,707.00 -19.5%0.5%2.2 $1.37 9/15/202275,900 shares $132,825.00 +22.0%0.6%1.7 $1.75 8/31/202262,200 shares $136,218.00 -13.6%0.5%1 $2.19 8/15/202272,000 shares $154,800.00 -31.8%0.6%0.5 $2.15 7/31/2022105,600 shares $195,360.00 +16.3%0.9%0.7 $1.85 7/15/202290,800 shares $171,612.00 -26.7%0.8%0.5 $1.89 6/30/2022123,900 shares $215,586.00 -71.2%1.0%0.7 $1.74 6/15/2022429,700 shares $687,520.00 +2.8%3.6%2.3 $1.60 5/31/2022417,900 shares $651,924.00 +8.2%3.5%2.2 $1.56 5/15/2022386,200 shares $525,232.00 -0.5%3.2%3.1 $1.36 4/30/2022388,300 shares $683,408.00 +2.5%3.5%2.8 $1.76 4/15/2022378,700 shares $802,844.00 +21.3%3.4%2.2 $2.12 3/31/2022312,100 shares $627,321.00 -5.1%3.5%1 $2.01 3/15/2022328,700 shares $608,095.00 -17.8%4.6%0.2 $1.85 2/28/2022399,900 shares $907,773.00 -4.4%5.6%0.1 $2.27 2/15/2022418,300 shares $962,090.00 -7.6%5.9%0.1 $2.30 1/31/2022452,600 shares $1.15 million -10.5%6.4%0.1 $2.54 1/15/2022505,400 shares $1.73 million -58.2%6.4%0.1 $3.43 12/31/20211,210,000 shares $5.40 million +78.7%17.1%0.3 $4.46 12/15/2021677,300 shares $1.69 million +28.4%9.6%0.2 $2.50 11/30/2021527,700 shares $1.36 million +10.8%7.5%3.9 $2.58 11/15/2021476,200 shares $2.09 million -0.7%6.8%4.4 $4.39 10/29/2021479,500 shares $2.28 million +2.0%6.8%7.7 $4.76 10/15/2021470,100 shares $2.11 million -3.0%6.0%9.6 $4.48 9/30/2021484,700 shares $2.91 million -10.5%6.2%11.2 $6.01 9/15/2021541,500 shares $3.91 million +1.3%7.0%10.3 $7.22 8/31/2021534,700 shares $4.10 million +0.6%6.9%8.7 $7.67 8/13/2021531,500 shares $4.08 million +9.3%6.9%8.9 $7.67 7/30/2021486,400 shares $4.48 million -1.6%6.3%6.9 $9.21 7/15/2021494,100 shares $4.91 million -3.1%6.4%6.1 $9.94Claim Your FREE Protection Guide (Ad)In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now → 6/30/2021510,100 shares $5.72 million +5.6%6.6%6.4 $11.21 6/15/2021483,300 shares $5.62 million +6.5%6.2%6.8 $11.63 5/28/2021454,000 shares $6.42 million -1.9%5.9%6.4 $14.13 5/14/2021462,800 shares $6.76 million +3.2%6.4%6.7 $14.60 4/30/2021448,500 shares $7.83 million -4.6%6.2%7.9 $17.46 4/15/2021470,100 shares $7.46 million +9.9%6.5%9.6 $15.87 3/31/2021427,800 shares $6.51 million +9.1%5.9%9.5 $15.21 3/15/2021392,300 shares $10.12 million +0.7%5.4%5.9 $25.79 2/26/2021389,600 shares $8.26 million +3.3%5.4%6.2 $21.21 2/12/2021377,300 shares $8.05 million -1.4%5.2%5.8 $21.34 1/29/2021382,500 shares $7.68 million -3.8%6.2%5 $20.08 1/15/2021397,400 shares $9.41 million No Change6.4%4.7 $23.69 SPRB Short Interest - Frequently Asked Questions What is Spruce Biosciences' current short interest? Short interest is the volume of Spruce Biosciences shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 136,400 shares of SPRB short. 0.36% of Spruce Biosciences' shares are currently sold short. Learn More on Spruce Biosciences' current short interest. Which institutional investors are shorting Spruce Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Spruce Biosciences: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Spruce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of Spruce Biosciences' floating shares are currently sold short. Is Spruce Biosciences' short interest increasing or decreasing? Spruce Biosciences saw a decline in short interest in March. As of March 31st, there was short interest totaling 136,400 shares, a decline of 48.7% from the previous total of 265,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Spruce Biosciences' short interest compare to its competitors? 0.36% of Spruce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Spruce Biosciences: Oncolytics Biotech Inc. (3.20%), Verrica Pharmaceuticals Inc. (10.89%), PMV Pharmaceuticals, Inc. (1.91%), ImmuCell Co. (0.23%), Sutro Biopharma, Inc. (6.91%), PDS Biotechnology Co. (9.27%), Cue Biopharma, Inc. (1.53%), CytomX Therapeutics, Inc. (12.86%), BeyondSpring Inc. (6.24%), Acrivon Therapeutics, Inc. (4.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Spruce Biosciences stock? Short selling SPRB is an investing strategy that aims to generate trading profit from Spruce Biosciences as its price is falling. SPRB shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spruce Biosciences? A short squeeze for Spruce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRB, which in turn drives the price of the stock up even further. How often is Spruce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRB, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Oncolytics Biotech Short Interest Data Verrica Pharmaceuticals Short Interest Data PMV Pharmaceuticals Short Interest Data ImmuCell Short Interest Data Sutro Biopharma Short Interest Data PDS Biotechnology Short Interest Data Cue Biopharma Short Interest Data CytomX Therapeutics Short Interest Data BeyondSpring Short Interest Data Acrivon Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRB) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spruce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPRB Stock Free SPRB Stock Alerts